In a first, Regeneron's antibody cocktail reduces deaths for a subgroup of hospitalized Covid-19 patients
Scientists have come up with the first evidence that Regeneron’s antibody cocktail, which has so far only been authorized for the outpatient setting, may reduce …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
